14 results on '"Banff schema"'
Search Results
2. An approach to allograft renal biopsy interpretation for the beginner- A narrative review
- Author
-
Swarnalata Gowrishankar
- Subjects
Transplantation ,medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,General surgery ,Transplant recipient ,banff ,lcsh:Surgery ,Banff schema ,Disease ,lcsh:RD1-811 ,allograft renal biopsy ,Schema (psychology) ,Biopsy ,medicine ,Narrative review ,Renal biopsy ,Medical diagnosis ,rejection ,business - Abstract
Allograft renal biopsy remains the gold standard for diagnosing many conditions in the transplant recipient including rejections, infections, recurrent, and de-novo renal disease. The Banff schema of reporting is followed worldwide in arriving at the right diagnosis. The guidelines, the categories, and the Banff scores in this schema are constantly evolving and this has made the interpretation of the biopsy seem complex and difficult especially for the novice. In this review, a detailed description of the various patterns of injury specific to the graft, the Banff categories of diagnoses, the lesions, and the Banff scores are simplified and explained. Lastly, a systematic approach to these allograft biopsies, which can be followed in regular practice, and by which a tentative diagnosis can be made in most cases is laid out.
- Published
- 2020
3. Clinical significance of isolated v lesions in paediatric renal transplant biopsies: muscular arteries required to refute the diagnosis of acute rejection.
- Author
-
Brown, Chrysothemis C., Sebire, Neil J., Wittenhagen, Per, Shaw, Olivia, and Marks, Stephen D.
- Subjects
- *
RENAL artery , *TRANSPLANTATION of organs, tissues, etc. in children , *GRAFT rejection , *T cells , *ENDARTERITIS , *TRANSPLANTATION of organs, tissues, etc. - Abstract
Intimal vascular lesions are considered features of acute T-cell-mediated rejection yet can occur in the absence of tubulointerstitial inflammation, termed isolated 'v' lesions. The clinical significance of these lesions is unclear. The diagnosis requires a biopsy with the presence of arteries. The frequency of adequate biopsies was analysed in 89 renal transplant biopsies from 57 paediatric renal allograft recipients, and the incidence of isolated endarteritis was determined. 60 (67%) biopsies contained an artery and of these, isolated 'v' lesions occurred in 6 (10%). 5 (83%) biopsies with isolated 'v' lesions were associated with positive DSA, suggesting that these lesions may represent acute antibody-mediated rejection. Patients with vessel-negative biopsies had an increased decline in eGFR (median −20.5, IQR −24.4 to 1.2 ml/min/1.73 m2 vs. −9.6, IQR −78.7 to −6.8 ml/min/1.73 m2; P = 0.01). Patients with vessel-negative biopsies were more likely to have repeat biopsy for ongoing allograft dysfunction, (25.0% vs. 2.4%; P < 0.01). The data suggest that isolated 'v' lesions are more common than previously thought. A significant proportion of biopsies classified as 'normal' or 'borderline change' in the absence of a large vessel may represent undiagnosed acute rejection. This may result in suboptimal therapy with possible adverse effects on renal outcome. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
4. Immunohistochemical characterization of glomerular and tubulointerstitial infiltrates in renal transplant patients with chronic allograft dysfunction.
- Author
-
Divella, Chiara, Rossini, Michele, Loverre, Antonia, Schena, Antonio, Maiorano, Annamaria, Gesualdo, Vincenzo, Zaza, Gianluigi, Grandaliano, Giuseppe, and Schena, Francesco Paolo
- Subjects
- *
KIDNEY diseases , *KIDNEY transplantation , *RENAL biopsy , *IMMUNOHISTOCHEMISTRY , *GLOMERULAR filtration rate , *HOMOGRAFTS , *T cells , *COMPARATIVE studies , *GRAFT rejection - Abstract
Background. The term chronic allograft nephropathy (CAN) was deleted in the Eighth Banff Classification and two new categories were introduced: chronic T-cell-mediated rejection (CTMR) and chronic active humoral rejection (CAHR). The aim of this study was to revise our CAN cases diagnosed in the last 4 years, analyse allograft survival rates and identify types of infiltrating cells in the different settings.Methods. Seventy-nine patients with biopsy-proven CAN were examined and classified into four groups according to the Banff 2005 criteria: CTMR, CAHR, chronic calcineurin inhibitor toxicity (CNITOX) and interstitial fibrosis and tubular atrophy not otherwise specified (NOS). CD4, CD8, CD20, CD68, CD103, Foxp3 and IL-17 protein expression and C4d deposits were investigated.Results. We diagnosed 20 CTMR, 13 CAHR, 28 CNITOX, and 18 NOS. Death-censored graft survival at 4 years from renal biopsy was worse in CAHR compared with the other types of chronic injury. Glomerular CD8+ cells were increased in CTMR vs CNITOX and NOS. Interstitial CD4+ and CD8+ cells were increased in CTMR vs CNITOX. CD68+ cells in glomerular and peritubular capillaries were higher in CAHR vs CNITOX, CTMR and NOS. CD103+ cells were higher in cases with tubulitis than in those without. T regulatory and T helper 17 cells were rarely observed in the different settings.Conclusions. Graft survival was worse in patients with CAHR. The presence of any grade transplant glomerulopathy and chronic allograft vasculopathy are poorer prognostic factors. Infiltrating CD8+, CD103+ and CD4+ cells may help to differentiate CTMR from other types of chronic injury, thus improving diagnostic/prognostic features of biopsy in patients with chronic allograft dysfunction. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
5. Computer-Assisted Definition of the Inflammatory Infiltrates in Patients With Different Categories of Banff Kidney Allograft Rejection
- Author
-
Antonio Núñez-Roldán, Isabel Aguilera, Alejandro Suárez-Benjumea, Elena Aguado-Dominguez, Rocío Cabrera-Pérez, Cristina Abad-Molina, Ministerio de Economía y Competitividad (España), Instituto de Salud Carlos III, Junta de Andalucía, and European Commission
- Subjects
0301 basic medicine ,Graft Rejection ,Male ,Pathology ,Banff Classification ,T-Lymphocytes ,Borderline diagnostic ,borderline diagnostic ,0302 clinical medicine ,Immunology and Allergy ,Diagnosis, Computer-Assisted ,Child ,Biopsy findings ,M1 macrophages ,Original Research ,Kidney ,B-Lymphocytes ,Cellular composition ,medicine.diagnostic_test ,Banff kidney classification ,Middle Aged ,NewCAST ,Allografts ,Killer Cells, Natural ,medicine.anatomical_structure ,Phenotype ,newCAST ,Allograft rejection ,antibody-mediated rejection ,Female ,Adult ,lcsh:Immunologic diseases. Allergy ,medicine.medical_specialty ,Adolescent ,inflammatory infiltrate ,Plasma Cells ,Immunology ,Antibodies ,biopsy findings ,Inflammatory infiltrate ,03 medical and health sciences ,Young Adult ,Immune system ,Biopsy ,medicine ,Humans ,In patient ,Aged ,Inflammation ,business.industry ,Macrophages ,banff kidney classification ,Banff schema ,Kidney Transplantation ,030104 developmental biology ,Antibody-mediated rejection ,business ,lcsh:RC581-607 ,030215 immunology - Abstract
Copyright © 2019 Aguado-Domínguez, Cabrera-Pérez, Suarez-Benjumea, AbadMolina, Núñez-Roldán and Aguilera., Currently, the diagnosis of kidney allograft rejection relies on individual histological assessments made by expert pathologists according to the Banff classification. In this study, we applied new Computer-Assisted System Technology (newCAST™) by Visiopharm® with the aim of identifying and quantifying the immune cells in inflammatory infiltrates. We searched for distinctive cellular profiles that could be assigned to each rejection category of the Banff schema: antibody-mediated rejection (active and chronic active), borderline, T cell-mediated rejection (TCMR), and mixed rejection. This study was performed with 49 biopsy samples, 42 from patients with rejection and 7 from patients with clinical signs of dysfunction but an absence of histological findings of rejection. Plasma cells, B and T lymphocytes, natural killer cells, and macrophages, with a special focus on the M1 and M2 subsets, were studied. A major difference among the Banff rejection groups was in the total amount of cells/mm2 tissue. Principal component analysis identified some distinctive associations. The borderline category grouped with CD4+ lymphocytes and M1 macrophages, and active antibody-mediated rejection (aAMR) clustered with natural killer cells. Despite these findings, the search for characteristic profiles linked to the rejection types proved to be a very difficult task since the cellular composition varied significantly among individuals within the same diagnostic category. The results of this study will be analyzed from the perspective of reconciling the classic way of diagnosing rejection and the immune situation “in situ” at the time of diagnosis., This study was supported by the Spanish Ministry of Economy, Instituto de Salud Carlos III, Grants 17/1403 and the Andalusian government, Consejería de Economía, Innovación, Ciencia y Empleo, Proyecto de Excelencia CTS-7846, and was co-funded by FEDER from the Regional Development European Funds (European Union).
- Published
- 2019
- Full Text
- View/download PDF
6. Glomerular C4d Immunoperoxidase in Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy.
- Author
-
Nankivell BJ, P'Ng CH, and Shingde M
- Abstract
Introduction: The diagnosis of late antibody-mediated rejection (AMR) is compromised by frequent absence of C4d in peritubular capillaries (C4d
ptc ), termed "C4d-negative" AMR. We hypothesized that glomerular capillary C4d (C4dglom ) reflected endothelial interaction with antibody and could improve immunologic classification of transplant glomerulopathy (TG)., Methods: We evaluated C4d using immunoperoxidase in 3524 consecutive, kidney transplant biopsies from a single center., Results: C4dglom was detected in 16.5% and C4dptc in 9.9% of biopsies. C4dglom occurred in 60.3% of TG ( n = 174) and was absent in normal glomeruli. Epidemiologic risk factors for C4dglom were younger, female, living-donor recipients with early AMR, prior treated rejection, and late presentation using multivariable analysis. Semiquantitative C4dglom score correlated with donor specific antibody (DSA) level, C4dptc , microvascular inflammation (MVI), Banff cg scores, renal dysfunction, and proteinuria. Principal component analysis colocalized C4dglom with histologic AMR. Multivariable analysis of TG found DSA, C4dptc , and post-transplant time associated with C4dglom . Addition of C4dglom into Banff chronic AMR schema improved its diagnostic sensitivity for TG (verified by electron microscopy [EM]) from 22.2% to 82.4% and accuracy from 59.6% to 93.9%, compared with Banff 2019 using only C4dptc . Tissue C4dglom and chronic AMR diagnosis incorporating C4dglom were associated with death-censored allograft failure in TG ( P < 0.001), independent of the severity of glomerulopathy and chronic interstitial fibrosis., Conclusion: C4dglom is a promising diagnostic biomarker of endothelial interaction with antibody which substantially improved test performance of the Banff schema to correctly classify TG by pathophysiology and prognosticate graft loss. We recommend routine C4d immunoperoxidase to minimize underdiagnosis of late AMR in TG., (© 2022 International Society of Nephrology. Published by Elsevier Inc.)- Published
- 2022
- Full Text
- View/download PDF
7. 2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology
- Author
-
Aurelio Sonzogni, Marta I. Minervini, Josh Levitsky, Maxwell L. Smith, A J Czaja, Stefan G. Hubscher, M O'Neil, M ElMonayeri, Hironori Haga, R Liotta, Banu Sis, Takaaki Koshiba, Robert B. Colvin, Sandy Feng, Mylène Sebagh, Oyedele Adeyi, Tomoo Itoh, Ozgul Sagol, Johan Mölne, Goran B. Klintmalm, Jan Lerut, Thomas D. Schiano, Parmjeet Randhawa, A Sanchez Fueyo, R Y Tanigawa, O Pappo, Wesam Ismail, Tomasz Kozlowski, John C. Bucuvalas, Carlos Thadeu Schmidt Cerski, Anthony J. Demetris, Phillip Ruiz, Giuseppe Tisone, F Charlotte, T Shimizu, Graeme J.M. Alexander, Desley Neil, Annette S. H. Gouw, Yoh Zen, Geoffrey W. McCaughan, Tong Wu, A. Zeevi, Atul K. Bhan, Imad Nasser, Stuart J. Knechtle, John Hart, George V. Mazariegos, Athanassios C. Tsamandas, Funda Yilmaz, Heather L. Stevenson, L Licini, Annika Wernerson, Jacqueline G. O'Leary, L Petrovic, Thalachallour Mohanakumar, Emma E. Furth, N C Jhala, Joseph Misdraji, Paulo Fontes, M. Shiller, Sara Hafezi-Bakhtiari, Ibrahim Batal, Swan N. Thung, A. Del Bello, Finn P. Reinholt, Charles Lassman, James Neuberger, M. E. de Vera, E Honsova, John J. Fung, L Baiocchi, Christopher Bellamy, M Balasubramanian, Abraham Shaked, Eizaburo Sasatomi, Urmila Khettry, Maria Isabel Fiel, and Groningen Institute for Organ Transplantation (GIOT)
- Subjects
Graft Rejection ,Research Report ,Pathology ,medicine.medical_specialty ,classification systems: Banff classification ,Acute cellular rejection ,medicine.medical_treatment ,rejection: T cell mediated (TCMR) ,ACUTE HUMORAL REJECTION ,Consensus criteria ,IDIOPATHIC PORTAL-HYPERTENSION ,immunosuppression/immune modulation ,030230 surgery ,Liver transplantation ,clinical research/practice ,NOVO AUTOIMMUNE HEPATITIS ,03 medical and health sciences ,0302 clinical medicine ,Isoantibodies ,HISTOCOMPATIBILITY COMPLEX ANTIGENS ,Immunology and Allergy ,Medicine ,Humans ,DONOR-SPECIFIC ANTIBODIES ,Pharmacology (medical) ,guidelines ,ACUTE CELLULAR REJECTION ,NORMAL HUMAN ORGANS ,Transplantation ,tolerance ,business.industry ,HUMAN-LEUKOCYTE ANTIGEN ,DIFFERENT STAINING TECHNIQUES ,Banff schema ,Immunosuppression ,Allografts ,liver transplantation/hepatology ,rejection: antibody-mediated (ABMR) ,Liver Transplantation ,Settore MED/18 ,Allograft rejection ,LYMPHOCYTOTOXIC CROSS-MATCH ,Antibody mediated rejection ,030211 gastroenterology & hepatology ,Tissue staining ,business - Abstract
The Banff Working Group on Liver Allograft Pathology reviewed and discussed literature evidence regarding antibody-mediated liver allograft rejection at the 11th (Paris, France, June 5-10, 2011), 12th (Comandatuba, Brazil, August 19-23, 2013), and 13th (Vancouver, British Columbia, Canada, October 5-10, 2015) meetings of the Banff Conference on Allograft Pathology. Discussion continued online. The primary goal was to introduce guidelines and consensus criteria for the diagnosis of liver allograft antibody-mediated rejection and provide a comprehensive update of all Banff Schema recommendations. Included are new recommendations for complement component 4d tissue staining and interpretation, staging liver allograft fibrosis, and findings related to immunosuppression minimization. In an effort to create a single reference document, previous unchanged criteria are also included.
- Published
- 2016
- Full Text
- View/download PDF
8. The Importance of Kidney Medullary Tissue for the Accurate Diagnosis of BK Virus Allograft Nephropathy.
- Author
-
Nankivell BJ, Renthawa J, Shingde M, and Khan A
- Subjects
- Adult, Allografts pathology, Antigens, Polyomavirus Transforming analysis, Biopsy standards, Female, Humans, Kidney Cortex pathology, Kidney Cortex virology, Kidney Diseases virology, Kidney Medulla virology, Kidney Transplantation, Male, Middle Aged, Prospective Studies, Viral Load, BK Virus, Kidney Diseases diagnosis, Kidney Diseases pathology, Kidney Medulla pathology, Polyomavirus Infections complications, Tumor Virus Infections complications
- Abstract
Background and Objectives: The published tissue adequacy requirement of kidney medulla for BK virus allograft nephropathy diagnosis lacks systematic verification and competes against potential increased procedural risks from deeper sampling., Design, Setting, Participants, & Measurements: We evaluated whether the presence of kidney medulla improved the diagnostic rate of BK nephropathy in 2244 consecutive biopsy samples from 856 kidney transplants with detailed histologic and virologic results., Results: Medulla was present in 821 samples (37%) and correlated with maximal core length ( r =0.35; P <0.001). BK virus allograft nephropathy occurred in 74 (3% overall) but increased to 5% (42 of 821) with medulla compared with 2% (32 of 1423) for cortical samples ( P <0.001). Biopsy medulla was associated with infection after comprehensive multivariable adjustment of confounders, including core length, glomerular number, and number of cores (adjusted odds ratio, 1.81; 95% confidence interval, 1.02 to 3.21; P =0.04). In viremic cases ( n =275), medulla was associated with BK virus nephropathy diagnosis (39% versus 19% for cortex; P <0.001) and tissue polyomavirus load (Banff polyomavirus score 0.64±0.96 versus 0.33±1.00; P =0.006). Biopsy medulla was associated with BK virus allograft nephropathy using generalized estimating equation (odds ratio, 2.04; 95% confidence interval, 1.05 to 3.96; n =275) and propensity matched score comparison (odds ratio, 2.24; 95% confidence interval, 1.11 to 4.54; P =0.03 for 156 balanced pairs). Morphometric evaluation of Simian virus 40 large T immunohistochemistry found maximal infected tubules within the inner cortex and medullary regions ( P <0.001 versus outer cortex)., Conclusions: Active BK virus replication concentrated around the corticomedullary junction can explain the higher detection rates for BK virus allograft nephropathy with deep sampling. The current adequacy requirement specifying targeting medulla can be justified to minimize a missed diagnosis from undersampling., (Copyright © 2020 by the American Society of Nephrology.)
- Published
- 2020
- Full Text
- View/download PDF
9. Evolution of the approaches toward grading and classifying chronic changes in the renal allograft: Banff classification updates III
- Author
-
Mubarak, Muhammed and Kazi, Javed I.
- Subjects
Banff schema ,chronic rejection ,sense organs ,tubular atrop ,interstitial fibrosis ,skin and connective tissue diseases ,chronic allograft nephropathy - Abstract
Currently, the most challenging problem in the field of renal and other solid organ transplantation is the development of chronic progressive sclerosing changes in the allograft. These occur almost uniformly in all renal allografts at a rate of 2-4% per year. In addition, such changes are also quite prevalent in well functioning grafts, as revealed by protocol biopsies. The chronic changes involve all the four components of the renal graft parenchyma, i.e., the glomeruli, blood vessels, tubules and interstitium. Among these, the glomerular and vascular changes are helpful in defining the causes of chronic changes, especially chronic rejection, but are more prone to sampling error, notably the blood vessels, whereas the tubulo-interstitial changes are less specific. However, because the later are less prone to sampling error, these are used for grading the severity of chronic changes in the Banff formulation. The identification, classification and grading of not only the acute but also the chronic changes is of vital importance in guiding the management and predicting the long-term graft outcome of renal transplant recipients. Banff has addressed the issue of chronic changes in detail in its first formulation, as well as its subsequent modifications. However, the magnitude of changes in this category that have occurred over the last two decades is less than that observed in the categories of antibody-mediated and T-cell-mediated rejections. This review describes in detail the changes that have taken place in the category of chronic allograft damage, as the original Banff classification has undergone updates regularly in the last two decades
- Published
- 2014
10. Pancreas allograft biopsies procedure in the management of pancreas transplant recipients.
- Author
-
Wan J, Fang J, Li G, Xu L, Yin W, Xiong Y, Liu L, Zhang T, Wu J, Guo Y, Ma J, and Chen Z
- Abstract
Pancreas transplantation is an effective therapy for diabetic patients, which can significantly improve the survival rate and quality of life of diabetic patients. According to the international registration of pancreas transplantation center, the global total pancreas transplantation has reached more than 80,000 cases by 2017, including pure pancreas transplantation and simultaneous pancreas-kidney transplantation (SPK). With the development and application of a new type of immunosuppressant, with the gradual maturity of organ preservation technology and surgical technology, the pancreas transplantation has rapidly on a global scale. However, pancreas transplantation still has more problems than limit its development compared with other organ transplantation. For example, the early diagnosis and treatment of pancreatic rejection are of considerable significance to the prognosis of pancreas transplantation. Some surveillance methods of diagnosis have been used increasingly, among which the histopathological diagnosis is particularly important. The first Banff schema for the histological diagnosis of pancreas rejection has been published, which primarily dealt with the diagnosis of acute T-cell-mediated rejection (ACMR). In recent years, antibody-mediated rejection (AMR) has been more emphasized as the primary cause of graft failure. The Banff pancreas allograft rejection grading schema was updated in 2011 by a broad-based multidisciplinary panel, presenting comprehensive guidelines for the diagnosis of AMR., Competing Interests: Conflicts of Interest: The authors have no conflicts of interest to declare., (2019 Gland Surgery. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
11. Evolution of the diagnostic criteria of T-cell-mediated rejection of renal allografts: Banff classification updates II
- Author
-
Mubarak, Muhammed and Kazi, Javed I.
- Subjects
borderline changes ,Banff schema ,cell-mediated rejection ,T cells ,kidney transplantation - Abstract
The allo-specific immune responses to transplanted tissues or organs represent one of the most formidable challenges in the field of transplantation. Traditionally, cell-mediated alloimmune responses were considered the preeminent cause of rejection and have remained the focus of immunosuppressive drugs during the last several decades. More recently, attention has also been directed to the alloantibody-mediated damage and the innate immune system in initiating and effecting the immune injury to the transplanted organs. As a corollary to the above considerations, the earlier Banff classifications focused more on diagnosing and categorizing cellular rejection. There have occurred some significant changes in the cell-mediated rejection in recent Banff updates, but the changes are not as drastic or widespread, as those of the antibody-mediated rejection. Acute/active cell-mediated rejection may occur early or considerably late after renal transplantation. In this context, the terms of acute and chronic are not synonymous to their traditional connotations in pathology in terms of speed or duration of reaction. Acute rejection may occur many years after transplantation, and conversely, chronic changes may be present in the graft from the outset, derived from donor changes. Acute/active cell-mediated rejection, although markedly reduced in recent years, still remains one of the common causes of both acute and chronic renal allograft injury and dysfunction throughout the world. Luckily, a vast majority of cases of acute/active cell-mediated rejection respond rapidly and completely to the conventional anti-rejection treatment. In spite of this, it remains one of the most important causes of graft loss, especially in the long-term. Renal allograft biopsy still remains the gold standard test for an accurate diagnosis and categorization of cell-mediated rejection. A standardized approach to renal biopsy study is necessary if the full benefits of this invasive procedure are to be realized. Prior to the early 1990s, there were no uniformly accepted criteria for the diagnosis and classification of renal allograft pathology in general and rejection in particular. During early 1990s, a group of dedicated nephropathologists, clinicians and basic scientists set out to standardize the histopathological study of renal allograft biopsies for the uniform reporting of the pathological lesions across the world. These efforts have continued since then and have resulted in marked refinements in the diagnostic criteria and categories of rejection observed on renal allograft biopsies. The present paper forms the second attempt of the series to address the evolutionary changes in the diagnostic criteria and the classification of the rejection process on renal allograft biopsies as these took place over the years since the early 1990s. An earlier paper described in detail the changes that occurred in the category of antibody-mediated rejection. In this paper, we will discuss the changes that have occurred in the diagnosis and categorization of cell-mediated rejection and the focus, as in previous paper, will be on the morphological findings as observed on renal allograft biopsies.
- Published
- 2013
12. The art of classifying renal allograft pathology
- Author
-
Jan J. Weening and Other departments
- Subjects
Pathology ,medicine.medical_specialty ,Scoring system ,business.industry ,Banff schema ,General Medicine ,Interstitial inflammation ,Transplantation ,Complement 4d ,Nephrology ,Renal transplant ,Renal allograft ,Medicine ,business ,Research data - Abstract
This Practice Point commentary discusses Solez et al.'s most recent update to the Banff criteria for the classification of renal transplant pathology. The update focused on various aspects of antibody-mediated rejection, in particular the incorporation of a validated scoring system for peritubular capillary complement 4d staining and inflammation. A new scoring system for interstitial inflammation was also introduced, to be tested over the next 2 years. The report advocates the application of the Banff schema to zero-time and protocol biopsies, and several working groups have been set up to investigate the importance of new research data (including genomics and proteomics) for practical use. This commentary describes the new additions and proposals and places them in perspective.
- Published
- 2008
- Full Text
- View/download PDF
13. Banff fibrosis study: multicenter visual assessment and computerized analysis of interstitial fibrosis in kidney biopsies.
- Author
-
Farris AB, Chan S, Climenhaga J, Adam B, Bellamy CO, Serón D, Colvin RB, Reeve J, and Mengel M
- Subjects
- Biopsy, Fibrosis metabolism, Follow-Up Studies, Humans, Immunoenzyme Techniques, Kidney Tubules metabolism, Observer Variation, Prognosis, Collagen Type III metabolism, Fibrosis classification, Fibrosis pathology, Image Processing, Computer-Assisted, Kidney Tubules pathology
- Abstract
Increasing interstitial fibrosis (IF) in native and kidney transplant biopsies is associated with functional decline and serves as a clinical trial end point. A Banff 2009 Conference survey revealed a range in IF assessment practices. Observers from multiple centers were asked to assess 30 renal biopsies with a range of IF and quantitate IF using two approaches on trichrome, Periodic acid-Schiff (PAS) and computer-assisted quantification of collagen III immunohistochemistry (C-IHC) slides, as well as assessing percent of cortical tubular atrophy% (TA%) and Banff total cortical inflammation score (ti-score). C-IHC using whole slide scans was performed. C-IHC assessment showed a higher correlation with organ function (r = -0.48) than did visual assessments (r = -0.32--0.42); computerized and visual C-IHC assessment also correlated (r = 0.64-0.66). Visual assessment of trichrome and C-IHC showed better correlations with organ function and C-IHC, than PAS, TA% and ti-score. However, visual assessment of IF, independent of approach, was variable among observers, and differences in correlations with organ function were not statistically significant among C-IHC image analysis and visual assessment methods. C-IHC image analysis correlated among three centers (r > 0.90, p < 0.0001, between all centers). Given the difficulty of visual IF assessment standardization, C-IHC image could potentially accomplish standardized IF assessment in multicenter settings., (© Copyright 2014 The American Society of Transplantation and the American Society of Transplant Surgeons.)
- Published
- 2014
- Full Text
- View/download PDF
14. Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.
- Author
-
Haas M, Sis B, Racusen LC, Solez K, Glotz D, Colvin RB, Castro MC, David DS, David-Neto E, Bagnasco SM, Cendales LC, Cornell LD, Demetris AJ, Drachenberg CB, Farver CF, Farris AB 3rd, Gibson IW, Kraus E, Liapis H, Loupy A, Nickeleit V, Randhawa P, Rodriguez ER, Rush D, Smith RN, Tan CD, Wallace WD, and Mengel M
- Subjects
- Arteritis metabolism, Graft Rejection metabolism, Humans, Research Report, Arteritis etiology, Complement C4b metabolism, Graft Rejection etiology, Isoantibodies immunology, Organ Transplantation adverse effects, Peptide Fragments metabolism
- Abstract
The 12th Banff Conference on Allograft Pathology was held in Comandatuba, Brazil, from August 19-23, 2013, and was preceded by a 2-day Latin American Symposium on Transplant Immunobiology and Immunopathology. The meeting was highlighted by the presentation of the findings of several working groups formed at the 2009 and 2011 Banff meetings to: (1) establish consensus criteria for diagnosing antibody-mediated rejection (ABMR) in the presence and absence of detectable C4d deposition; (2) develop consensus definitions and thresholds for glomerulitis (g score) and chronic glomerulopathy (cg score), associated with improved inter-observer agreement and correlation with clinical, molecular and serological data; (3) determine whether isolated lesions of intimal arteritis ("isolated v") represent acute rejection similar to intimal arteritis in the presence of tubulointerstitial inflammation; (4) compare different methodologies for evaluating interstitial fibrosis and for performing/evaluating implantation biopsies of renal allografts with regard to reproducibility and prediction of subsequent graft function; and (5) define clinically and prognostically significant morphologic criteria for subclassifying polyoma virus nephropathy. The key outcome of the 2013 conference is defining criteria for diagnosis of C4d-negative ABMR and respective modification of the Banff classification. In addition, three new Banff Working Groups were initiated., (© Copyright 2014 The American Society of Transplantation and the American Society of Transplant Surgeons.)
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.